Home › Employers › Envision Pharma, Inc.
Envision Pharma, Inc.: H-1B salaries and sponsorship
Envision Pharma, Inc. filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $109,439.
Does Envision Pharma, Inc. sponsor H-1B visas?
Envision Pharma, Inc. filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Sep 17, 2024. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Medical Writer | 1 | $73,000 |
| Software Developer III | 1 | $117,208 |
| Senior Medical Writer | 1 | $101,670 |
| Manager, Strategic Consulting | 1 | $160,000 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 1 | $73,000 |
| FY2024 | 3 | $117,208 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Manager, Strategic Consulting | $160,000–$213,002 Level IV | Somerset, NJ | Sep 17, 2024 | Sep 30, 2024 | Certified |
| Software Developer III | $117,208–$153,380 Level III | Newington, CT | Apr 24, 2024 | Oct 1, 2024 | Certified |
| Senior Medical Writer | $101,670–$136,507 Level II | Fairfield, CT | Apr 5, 2024 | May 15, 2024 | Certified |
| Medical Writer | $73,000–$110,000 Level II | Chicago, IL | May 8, 2023 | Oct 1, 2023 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).